BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38336516)

  • 1. Pathological findings associated with the updated European Society of Cardiology 2022 guidelines for preoperative cardiac testing: an observational cohort modelling study.
    Stroda A; Mauermann E; Ionescu D; Szczeklik W; De Hert S; Filipovic M; Beck Schimmer B; Spadaro S; Matute P; Ganter MT; Ovezov A; Turhan SC; van Waes J; Lagarto F; Theodoraki K; Gupta A; Gillmann HJ; Guzzetti L; Kotfis K; Larmann J; Corneci D; Buggy DJ; Howell SJ; Lurati Buse G;
    Br J Anaesth; 2024 Apr; 132(4):675-684. PubMed ID: 38336516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to the European Society of Cardiology/European Society of Anaesthesiology recommendations on preoperative cardiac testing and association with positive results and cardiac events: a cohort study.
    Lurati Buse GAL; Puelacher C; Gualandro DM; Kilinc D; Glarner N; Hidvegi R; Bolliger D; Arslani K; Lampart A; Steiner LA; Kindler C; Wolff T; Mujagic E; Guerke L; Mueller C;
    Br J Anaesth; 2021 Sep; 127(3):376-385. PubMed ID: 34330416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
    Feringa HH; Schouten O; Dunkelgrun M; Bax JJ; Boersma E; Elhendy A; de Jonge R; Karagiannis SE; Vidakovic R; Poldermans D
    Heart; 2007 Feb; 93(2):226-31. PubMed ID: 16914484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.
    Singh HS; Bibbins-Domingo K; Ali S; Wu AH; Schiller NB; Whooley MA
    Clin Cardiol; 2009 Aug; 32(8):447-53. PubMed ID: 19685518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of N-terminal pro B-type natriuretic peptide in identifying patients at high risk for adverse outcome after emergent non-cardiac surgery.
    Farzi S; Stojakovic T; Marko T; Sankin C; Rehak P; Gumpert R; Baumann A; Höfler B; Metzler H; Mahla E
    Br J Anaesth; 2013 Apr; 110(4):554-60. PubMed ID: 23248094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
    Pareek M
    Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of using different guideline recommended serum natriuretic peptide thresholds on the diagnosis and referral rates of a diagnostic heart failure clinic.
    Fazal IA; Bhagra SK; Bailey KM; Dermot Neely R; MacGowan GA; Skinner JS
    Int J Clin Pract; 2015 Nov; 69(11):1349-56. PubMed ID: 26194330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.
    Mishra RK; Beatty AL; Jaganath R; Regan M; Wu AH; Whooley MA
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25053234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-B-type natriuretic peptide concentrations and long-term outcome after cardiac surgery: a prospective cohort study.
    Cuthbertson BH; Croal BL; Rae D; Harrild K; Gibson PH; Prescott GJ; Kengne AP; Hillis GS
    Br J Anaesth; 2013 Feb; 110(2):214-21. PubMed ID: 23183321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis.
    Aljama MA; Sidiqi MH; Dispenzieri A; Gertz MA; Lacy MQ; Buadi FK; Dingli D; Muchtar E; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Warsame RM; Kourelis T; Hwa YL; Kapoor P; Leung N; Go RS; Kyle RA; Rajkumar SV; Kumar SK
    Blood Adv; 2019 Apr; 3(8):1226-1229. PubMed ID: 30975646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.
    Dietl A; Stark K; Zimmermann ME; Meisinger C; Schunkert H; Birner C; Maier LS; Peters A; Heid IM; Luchner A
    PLoS One; 2016; 11(10):e0164060. PubMed ID: 27711172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery.
    Oscarsson A; Fredrikson M; Sörliden M; Anskär S; Eintrei C
    Br J Anaesth; 2009 Aug; 103(2):206-12. PubMed ID: 19525507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of perioperative N-terminal pro-B-type natriuretic peptide in noncardiac surgery.
    Borges FK; Furtado MV; Rossini AP; Bertoluci C; Gonzalez VL; Bertoldi EG; Grutcki DM; Rech LG; Magalhães M; Polanczyk CA
    Arq Bras Cardiol; 2013 Jun; 100(6):561-70. PubMed ID: 23657264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma N-terminal pro-B-type natriuretic peptide is predictive of perioperative cardiac events in patients undergoing vascular surgery.
    Yang JH; Choi JH; Ki YW; Kim DI; Kim DK; Park JR; Oh JK; Choi SH
    Korean J Intern Med; 2012 Sep; 27(3):301-10. PubMed ID: 23019395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of N-terminal-proBNP in differentiating acute pulmonary embolism from heart failure in patients with acute dyspnea.
    Guo L; Li G; Wang Y; Liang H; Shan X; Zhang N; Wang M; Lin D; Zhu L
    Chin Med J (Engl); 2014; 127(16):2888-93. PubMed ID: 25131222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery.
    Liu H; Wang C; Liu L; Zhuang Y; Yang X; Zhang Y
    J Cardiothorac Surg; 2013 Jan; 8():1. PubMed ID: 23289601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.